Skip to main content

Medicinova Inc

MNOV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001226616

In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Medicinova Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of MNOV: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders39142+4
Shares7.65M11.8K7.62M−12.8K (−0.2%)
Value$29.0M$45.0K$20.4M−$8.52M (−29.4%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Medicinova Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to MNOV in Q4 2021
InstitutionSharesValue% of portfolio
Anson Funds Management LP131,495$352.0K0.05%
Capricorn Fund Managers Ltd53,700$144.0K0.04%
Schonfeld Strategic Advisors LLC44,600$119.0K0.00%
Jane Street Group, LLC29,542$79.0K0.00%
Bank Julius Baer & Co. Ltd, Zurich19,000$51.0K0.00%
Qube Research & Technologies Ltd13,797$37.0K0.00%
Buckingham Strategic Partners10,000$27.0K0.01%
Eaton Vance Management1,100$3.00K0.00%
Wells Fargo & Company320$1.00K0.00%

Sold out (5)

Institutions that held Medicinova Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of MNOV in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Simplex Trading, LLC13,718$56.0K
D. E. Shaw & Co., Inc.12,847$49.0K
ProShare Advisors LLC10,461$40.0K
Penserra Capital Management LLC1,120$4.00K
Daiwa Securities Group Inc.84$0

Not filed for Q4 2021 yet (1)

Institutions that held Medicinova Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MNOV in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Marshall Wace North America L.P.11,800$45.0K